AP Radio AP Radio News:

Jan 12, 1:36 PM EST

US OKs 1st drug aimed at women with inherited breast cancer



Multimedia
When Drugs Stop Working
Lone Protestor Rallies Ohio City Against Drugs
From Drug Addict to Counselor
Documents
CDC Report on Sexual Behavior and Drug Use
Latest News
Hospital groups creating company to make cheap generic drugs

US OKs 1st drug aimed at women with inherited breast cancer

Multimedia
Drug war interactive

U.S. regulators have approved the first drug aimed at women with advanced breast cancers caused by an inherited flawed gene.

The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza (lihn-PAHR'zah) for patients with inherited BRCA gene mutations who have undergone chemotherapy.

It's the first in a fairly new class of medicines for ovarian cancer called PARP inhibitors to also win approval for treating breast cancer.

PARP inhibitors prevent cancer cells from fixing problems in their DNA. Blocking that can result in those cells dying or tumor growth slowing or even stopping.

AstraZeneca says Lynparza will cost $13,886 per month without insurance.

Possible side effects are less severe than for chemo, but can include serious ones such as blood and bone marrow cancers.

© 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.